High-intensity interval training and thromboembolic events during chemotherapy for testicular cancer: a retrospective analysis from the Body & Cancer cohort

References

• Smith ZL, Werntz RP, Eggener SE. Testicular cancer: epidemiology, diagnosis, and management. Med Clin North Am. 2018;102(2):251–264. doi: 10.1016/j.mcna.2017.10.003.
   PubMed Web of Science ®Google Scholar
• Znaor A, Skakkebaek NE, Rajpert-De Meyts E, et al. Global patterns in testicular cancer incidence and mortality in 2020. Int J Cancer. 2022;151(5):692–698.
   PubMed Web of Science ®Google Scholar
• Sprauten M, Haugnes HS, Brydoy M, et al. Chronic fatigue in 812 testicular cancer survivors during long-term follow-up: increasing prevalence and risk factors. Ann Oncol. 2015;26(10):2133–2140. doi: 10.1093/annonc/mdv328.
   PubMed Web of Science ®Google Scholar
• Fossa SD, de Wit R, Roberts JT, et al. Quality of life in good prognosis patients with metastatic germ cell cancer: a prospective study of the european organization for research and treatment of cancer genitourinary group/medical research council testicular cancer study group (30941/TE20). J Clin Oncol. 2003;21(6):1107–1118. doi: 10.1200/JCO.2003.02.075.
   PubMed Web of Science ®Google Scholar
• Chovanec M, Lauritsen J, Bandak M, et al. Late adverse effects and quality of life in survivors of testicular germ cell tumour. Nat Rev Urol. 2021;18(4):227–245. doi: 10.1038/s41585-021-00440-w.
   PubMed Web of Science ®Google Scholar
• Christensen JF, Bandak M, Campbell A, et al. Treatment-related cardiovascular late effects and exercise training countermeasures in testicular germ cell cancer survivorship. Acta Oncol. 2015;54(5):592–599. doi: 10.3109/0284186X.2014.995776.
   PubMed Web of Science ®Google Scholar
• Lauritsen J, Hansen MK, Bandak M, et al. Cardiovascular risk factors and disease after male germ cell cancer. J Clin Oncol. 2020;38(6):584–592. doi: 10.1200/JCO.19.01180.
   PubMed Web of Science ®Google Scholar
• Fung C, Fossa SD, Milano MT, et al. Cardiovascular disease mortality after chemotherapy or surgery for testicular nonseminoma: a Population-Based study. J Clin Oncol. 2015;33(28):3105–3115. doi: 10.1200/JCO.2014.60.3654.
   PubMed Web of Science ®Google Scholar
• Amiri A, Chovanec M, Oliva V, et al. Chemotherapy-induced toxicity in patients with testicular germ cell tumors: the impact of physical fitness and regular exercise. Andrology. 2021;9(6):1879–1892. doi: 10.1111/andr.13078.
   PubMed Web of Science ®Google Scholar
• Campbell KL, Winters-Stone KM, Wiskemann J, et al. Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable. Med Sci Sports Exerc. 2019;51(11):2375–2390. doi: 10.1249/MSS.0000000000002116.
   PubMed Web of Science ®Google Scholar
• Christensen JF, Jones LW, Tolver A, et al. Safety and efficacy of resistance training in germ cell cancer patients undergoing chemotherapy: a randomized controlled trial. Br J Cancer. 2014;111(1):8–16. doi: 10.1038/bjc.2014.273.
   PubMed Web of Science ®Google Scholar
• Thorsen L, Kirkegaard C, Loge JH, et al. Feasibility of a physical activity intervention during and shortly after chemotherapy for testicular cancer. BMC Res Notes. 2017;10(1):214. doi: 10.1186/s13104-017-2531-y.
   PubMedGoogle Scholar
• Adams SC, DeLorey DS, Davenport MH, et al. Effects of high-intensity aerobic interval training on cardiovascular disease risk in testicular cancer survivors: a phase 2 randomized controlled trial. Cancer. 2017;123(20):4057–4065. doi: 10.1002/cncr.30859.
   PubMed Web of Science ®Google Scholar
• Adams SC, DeLorey DS, Davenport MH, et al. Effects of high-intensity interval training on fatigue and quality of life in testicular cancer survivors. Br J Cancer. 2018;118(10):1313–1321. doi: 10.1038/s41416-018-0044-7.
   PubMed Web of Science ®Google Scholar
• Thorsen L, Haugnes HS, Fossa SD, et al. Thromboembolic events after high-intensity training during cisplatin-based chemotherapy for testicular cancer: case reports and review of the literature. Int J Cancer. 2020;147(11):3189–3198. doi: 10.1002/ijc.33151.
   PubMed Web of Science ®Google Scholar
• Adamsen L, Quist M, Andersen C, et al. Effect of a multimodal high intensity exercise intervention in cancer patients undergoing chemotherapy: randomised controlled trial. BMJ. 2009;339:b3410. doi: 10.1136/bmj.b3410.
   PubMed Web of Science ®Google Scholar
• Cuschieri S. The STROBE guidelines. Saudi J Anaesth. 2019; 13(Suppl 1):S31–S34. doi: 10.4103/sja.SJA_543_18.
   PubMed Web of Science ®Google Scholar
• Levinger I, Goodman C, Hare DL, et al. The reliability of the 1RM strength test for untrained middle-aged individuals. J Sci Med Sport. 2009;12(2):310–316. doi: 10.1016/j.jsams.2007.10.007.
   PubMed Web of Science ®Google Scholar
• Andersen LB. A maximal cycle exercise protocol to predict maximal oxygen uptake. Scand J Med Sci Sports. 1995; 5(3):143–146. doi: 10.1111/j.1600-0838.1995.tb00027.x.
   PubMedGoogle Scholar
• Quist M, Rorth M, Zacho M, et al. High-intensity resistance and cardiovascular training improve physical capacity in cancer patients undergoing chemotherapy. Scand J Med Sci Sports. 2006;16(5):349–357. doi: 10.1111/j.1600-0838.2005.00503.x.
   PubMed Web of Science ®Google Scholar
• Grimby G, Borjesson M, Jonsdottir IH, et al. The ‘Saltin-Grimby physical activity level scale’ and its application to health research. Scand J Med Sci Sports. 2015;25 Suppl 4(Suppl 4):119–125. doi: 10.1111/sms.12611.
   PubMed Web of Science ®Google Scholar
• International germ cell consensus classification: a prognostic factor-based staging system for metastatic germ cell cancers. International germ cell cancer collaborative group. J Clin Oncol. 1997; 15(2):594–603.
   PubMed Web of Science ®Google Scholar
• Horwich A, Dearnaley DP, Duchesne GM, et al. Simple nontoxic treatment of advanced metastatic seminoma with carboplatin. J Clin Oncol. 1989;7(8):1150–1156. doi: 10.1200/JCO.1989.7.8.1150.
   PubMed Web of Science ®Google Scholar
• Khorana AA, Kuderer NM, Culakova E, et al. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood. 2008;111(10):4902–4907. doi: 10.1182/blood-2007-10-116327.
   PubMed Web of Science ®Google Scholar
• Dieckmann KP, Marghawal D, Pichlmeier U, et al. Thromboembolic events in patients with testicular germ cell tumours are predominantly triggered by advanced disease and by central venous access systems. Urol Int. 2021;105(3-4):257–263. doi: 10.1159/000512055.
   PubMed Web of Science ®Google Scholar
• Bezan A, Posch F, Ploner F, et al. Risk stratification for venous thromboembolism in patients with testicular germ cell tumors. PLoS One. 2017;12(4):e0176283. doi: 10.1371/journal.pone.0176283.
   PubMed Web of Science ®Google Scholar
• Astrand I. Aerobic work capacity in men and women with special reference to age. Acta Physiol Scand Suppl. 1960;49(169):1–92.
   PubMedGoogle Scholar
• Cheng W, Zhang Z, Cheng W, et al. Associations of leisure-time physical activity with cardiovascular mortality: a systematic review and meta-analysis of 44 prospective cohort studies. Eur J Prev Cardiol. 2018;25(17):1864–1872. doi: 10.1177/2047487318795194.
   PubMed Web of Science ®Google Scholar
• Kunutsor SK, Makikallio TH, Seidu S, et al. Physical activity and risk of venous thromboembolism: systematic review and meta-analysis of prospective cohort studies. Eur J Epidemiol. 2020;35(5):431–442. doi: 10.1007/s10654-019-00579-2.
   PubMed Web of Science ®Google Scholar
• Franklin BA, Thompson PD, Al-Zaiti SS, et al. Exercise-related acute cardiovascular events and potential deleterious adaptations following long-term exercise training: placing the risks into perspective-an update: a scientific statement from the American heart association. Circulation. 2020;141(13):e705–e736. doi: 10.1161/CIR.0000000000000749.
   PubMed Web of Science ®Google Scholar
• Tuzovic M, Herrmann J, Iliescu C, et al. Arterial thrombosis in patients with cancer. Curr Treat Options Cardiovasc Med. 2018;20(5):40.
   PubMedGoogle Scholar
• Abdol Razak NB, Jones G, Bhandari M, et al. Cancer-associated thrombosis: an overview of mechanisms, risk factors, and treatment. Cancers. 2018;10(10):380. doi: 10.3390/cancers10100380.
   PubMed Web of Science ®Google Scholar
• Dieckmann KP, Struss WJ, Budde U. Evidence for acute vascular toxicity of cisplatin-based chemotherapy in patients with germ cell tumour. Anticancer Res. 2011; 31(12):4501–4505.
   PubMed Web of Science ®Google Scholar
• Moore RA, Adel N, Riedel E, et al. High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis. J Clin Oncol. 2011;29(25):3466–3473. doi: 10.1200/JCO.2011.35.5669.
   PubMed Web of Science ®Google Scholar
• Haugnes HS, Negaard HF, Jensvoll H, et al. Thromboembolic events during treatment with cisplatin-based chemotherapy in metastatic testicular germ-cell cancer 2000–2014: a population-based cohort study. Eur Urol Open Sci. 2021;32:19–27. doi: 10.1016/j.euros.2021.07.007.
   PubMedGoogle Scholar
• Olsen LN, Fischer M, Evans PA, et al. Does exercise influence the susceptibility to arterial thrombosis? An integrative perspective. Front Physiol. 2021;12:636027. doi: 10.3389/fphys.2021.636027.
   PubMed Web of Science ®Google Scholar
• Wewege MA, Ahn D, Yu J, et al. High-intensity interval training for patients with cardiovascular disease-Is it safe? A systematic review. J Am Heart Assoc. 2018;7(21):e009305.
   PubMed Web of Science ®Google Scholar
• Wallen MP, Hennessy D, Brown S, et al. High-intensity interval training improves cardiorespiratory fitness in cancer patients and survivors: a meta-analysis. Eur J Cancer Care (Engl). 2020;29(4):e13267. doi: 10.1111/ecc.13267.
   PubMed Web of Science ®Google Scholar
• Mugele H, Freitag N, Wilhelmi J, et al. High-intensity interval training in the therapy and aftercare of cancer patients: a systematic review with meta-analysis. J Cancer Surviv. 2019;13(2):205–223. doi: 10.1007/s11764-019-00743-3.
   PubMed Web of Science ®Google Scholar
• Lavin-Perez AM, Collado-Mateo D, Mayo X, et al. High-intensity exercise to improve cardiorespiratory fitness in cancer patients and survivors: a systematic review and meta-analysis. Scand J Med Sci Sports. 2021;31(2):265–294. doi: 10.1111/sms.13861.
   PubMed Web of Science ®Google Scholar
• Egegaard T, Rohold J, Lillelund C, et al. Pre-radiotherapy daily exercise training in non-small cell lung cancer: a feasibility study. Rep Pract Oncol Radiother. 2019;24(4):375–382. Jul-Augdoi: 10.1016/j.rpor.2019.06.003.
   PubMedGoogle Scholar
• Edvardsen E, Skjonsberg OH, Holme I, et al. High-intensity training following lung cancer surgery: a randomised controlled trial. Thorax. 2015;70(3):244–250. Mardoi: 10.1136/thoraxjnl-2014-205944.
   PubMed Web of Science ®Google Scholar
• Quist M, Langer SW, Lillelund C, et al. Effects of an exercise intervention for patients with advanced inoperable lung cancer undergoing chemotherapy: a randomized clinical trial. Lung Cancer. 2020;145:76–82. Juldoi: 10.1016/j.lungcan.2020.05.003.
   PubMed Web of Science ®Google Scholar